A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trial.
Barbara E StähliAxel LinkeDirk WestermannNicolas M Van MieghemDavid M LeistnerSteffen MassbergHannes AlberAndreas MüggeGiuseppe MusumeciRahel KesterkeSteffen SchneiderAdnan KastratiIan FordFrank RuschitzkaMarkus A Kaselnull nullBarbara E StähliMarkus KaselFrank RuschitzkaAxel LinkeNicolas Van MieghemSteffen MassbergDirk WestermannHannes AlberAndreas MüggeDavid M LeistnerGiuseppe MusumeciSteffen SchneiderAdnan KastratiIan FordStefano SavonittoBernhard WitzenbichlerMartin SwaansKarl SwedbergStuart PocockAldo MaggioniPublished in: American heart journal (2024)
The TAVI PCI trial tests the hypothesis that the strategy "PCI after TAVI" is noninferior to the strategy "PCI before TAVI" in patients with severe aortic stenosis and concomitant coronary artery disease.
Keyphrases
- transcatheter aortic valve implantation
- coronary artery disease
- aortic stenosis
- percutaneous coronary intervention
- aortic valve replacement
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- transcatheter aortic valve replacement
- aortic valve
- cardiovascular events
- ejection fraction
- acute coronary syndrome
- study protocol
- phase iii
- left ventricular
- clinical trial
- phase ii
- atrial fibrillation
- type diabetes
- drug induced
- open label
- early onset